Data Science and Diagnostic Models - the What, Why and How

On this episode of Data in Biotech, we’re excited to be joined by Michelle Wiest, Director of IVD Biostatistics at Freenome - a high-growth biotech company that creates tools to help prevent, detect, and treat disease.

Our own Ross Katz speaks with Michelle on the use of biostatistics in the field of diagnostics, what biases can corrupt diagnostic tests and how to catch them early, the different types of data sets that are being used to develop diagnostic models and how to prepare to present data to regulatory bodies such as the FDA.

Listen here:

If you’re a biotech company struggling to transform your business with data, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today.

Visit connect.corrdyn.com/biotech to learn more.

‍

Join newsletter

Stay up to date with new case studies. We promise no spam, just good content.

More blog posts

see all

How to Understand Your Customer Acquisition Cost and Lifetime Value

11 Questions to Decide Between an Open LLM and Third-Party LLM API for your Use Case

How are clients exploring generative machine learning for various use cases?

7 Principles for Determining Which LLM Business Cases Will Work, and Which Ones Will Fail

Interest in applying generative artificial intelligence and large language models to various business challenges has surged, prompting executives to redirect resources from traditional machine learning to bolster data science R&D focused on leveraging these technologies effectively.